Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,064.01
(
-0.63%
)
US TECH 100
25,958.80
(
0.72%
)
Dow Jones
49,149.38
(
-0.60%
)
Brent Oil
95.21
(
0.21%
)
Bitcoin
78,176.78
(
2.42%
)
News Focus
News Focus
Post# of 822368
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jon_k84

Send PM Follow Ignore
Followers 25
Posts 548
Boards Moderated 0
Alias Born 06/01/2018

jon_k84

Re: HyGro post# 560477

Thursday, 01/19/2023 12:26:56 AM

Thursday, January 19, 2023 12:26:56 AM

Post# of 822368
Part of the peer review process is to challenge parts of the trial. And let’s be clear, they are specifically challenging the use of external controls… the number of clinicians who support DCV is in the hundreds… 10 v 100… and all 10 dissenters are linked to NVCR which would get hit quite a bit if DCV is approved
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News